126 filings
8-K
IGMS
IGM Biosciences Inc
17 Apr 24
IGM Biosciences Announces Refocusing of Sanofi Collaboration
8:34am
PRE 14A
IGMS
IGM Biosciences Inc
Preliminary proxy
15 Apr 24
9:01am
S-8
IGMS
IGM Biosciences Inc
7 Mar 24
Registration of securities for employees
4:27pm
8-K
IGMS
IGM Biosciences Inc
7 Mar 24
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:10pm
10-K
2023 FY
IGMS
IGM Biosciences Inc
Annual report
7 Mar 24
4:05pm
8-K
ckomfht3o j11t9mly
8 Jan 24
Results of Operations and Financial Condition
9:00am
8-K
ugf7ctf78ui5addyk
8 Dec 23
IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
4:05pm
EFFECT
weavrw690jc
28 Nov 23
Notice of effectiveness
12:15am
CORRESP
j9hewkhhrosv
15 Nov 23
Correspondence with SEC
12:00am
UPLOAD
q5ov ivv9d
14 Nov 23
Letter from SEC
12:00am
8-K
da8kak r72lpz9u0zh
13 Nov 23
IGM Biosciences Announces Third Quarter 2023 Financial Results
4:10pm
8-K
2duad os3o8l2
3 Oct 23
Departure of Directors or Certain Officers
4:14pm
8-K
xqw03xja4hek33gq7oia
3 Aug 23
IGM Biosciences Announces Second Quarter 2023 Financial Results
4:13pm
D
obi91whf5 aknehe7u
7 Jul 23
Exempt offering of security
2:26pm
8-K
3nk2p pz7dc
27 Jun 23
Departure of Directors or Certain Officers
5:05pm
8-K
a90dfa 8b2ad60
23 Jun 23
Entry into a Material Definitive Agreement
4:41pm
424B5
pdvbwtqjq5n3qgsl
23 Jun 23
Prospectus supplement for primary offering
4:35pm